Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
about
Fragile X syndrome: A review of clinical managementSensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred miceRNAseq analysis of heart tissue from mice treated with atenolol and isoproterenol reveals a reciprocal transcriptional response.Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays.Drug-induced liver injury: what was new in 2013?Combining genetic and nongenetic biomarkers to realize the promise of pharmacogenomics for inflammatory diseases.Diagnostic utility of HLA-B*5801 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis.Association between infection and severe drug adverse reactions: an analysis using data from the Japanese Adverse Drug Event Report database.The chemical, genetic and immunological basis of idiosyncratic drug-induced liver injury.A web resource for mining HLA associations with adverse drug reactions: HLA-ADRSNP-based HLA allele tagging, imputation and association with antiepileptic drug-induced cutaneous reactions in Hong Kong Han Chinese.Comparison of exome-based HLA class I genotyping tools: identification of platform-specific genotyping errors.Is Universal HLA-B*15:02 Screening a Cost-Effective Option in an Ethnically-Diverse Population? A Case Study of Malaysia.Development of a simple genotyping method for the HLA-A*31:01-tagging SNP in Japanese.Acute severe liver dysfunction induced by febuxostat in a patient undergoing hemodialysis.Accuracy of SNPs to predict risk of HLA alleles associated with drug-induced hypersensitivity events across racial groups.Significance of functional disease-causal/susceptible variants identified by whole-genome analyses for the understanding of human diseases.Pharmacogenomics Implementation at the National Institutes of Health Clinical Center.A cluster of Epoetin-associated pure red cell aplasia: clinical features and the possible association of HLA-DRB1*12:02.Concomitant drug-induced liver and skin reactions: An Indian experience.Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients.
P2860
Q28076950-5AF1A869-1ADB-407A-9F2C-124B74D34544Q35071460-F92BE99F-EE56-44C4-AD50-0F3D216AD07FQ36125623-F20A5E5B-BD58-4BD7-90E7-188F830F3A13Q37590883-724028A0-A40A-4393-8AE5-82D50D376972Q38205591-82EFA8B4-A0DD-4442-A13B-9FA8E5D726C7Q38286234-846643A9-076B-4C45-928D-3A9CF4BCF020Q38600529-C790D9C7-9ADB-43C7-9945-477592341BFBQ38613096-6B103A78-DC42-4DA7-84A5-797455CD5656Q38651282-13635C8A-CF57-4E8C-BBAF-302C674D0032Q38836848-FD739B9D-F7B2-435C-B3EB-5C9B0C2D6FE3Q38842669-B58478D8-1EE3-487F-92FB-B572B5EDF0EDQ39157730-1265F5CF-7791-4212-BC9B-0A0D55BDBC0CQ40271934-1283C869-E910-476A-8440-2A9C8019B003Q40405160-DEEE6397-3382-44F4-9029-2AC487248712Q42290055-E2B001E3-2A2D-4954-8C3F-CB1275514288Q44858073-B062C809-6B6E-4088-AB92-291AA903738CQ47109078-51ABB48E-DE97-4A12-836A-7FDF876F53FDQ50045445-A444870E-F8B3-4C6A-8FB3-49EEBF6DAA48Q50236570-BA894335-395C-4161-BF11-6E499F6532A6Q54598463-B7467C6F-8DC3-4DAD-976F-070592BD252DQ55324381-690893AE-10A4-4F25-BAEF-F2C35F8798C0
P2860
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
@ast
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
@en
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
@nl
type
label
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
@ast
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
@en
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
@nl
prefLabel
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
@ast
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
@en
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
@nl
P2860
P356
P1476
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
@en
P2093
Nahoko Kaniwa
Yoshiro Saito
P2860
P2888
P304
P356
10.1038/JHG.2013.37
P577
2013-05-02T00:00:00Z
P5875
P6179
1012383802